Negrier C - Search Results

1

Pharmacokinetics of a novel extended half-life glycoPEGylated factor IX, nonacog beta pegol (N9-GP) in previously treated patients with haemophilia B: results from two phase 3 clinical trials.

Tiede A, Abdul-Karim F, Carcao M, Persson P, Clausen WHO, Kearney S, Matsushita T, Negrier C, Oldenburg J, Santagostino E, Young G. Tiede A, et al. Among authors: negrier c. Haemophilia. 2017 Jul;23(4):547-555. doi: 10.1111/hae.13191. Epub 2017 Feb 24. Haemophilia. 2017. PMID: 28233381 Clinical Trial.

2

An unusual haemarthrosis in an HIV-seronegative haemophilia A patient.

Ménart C, Duhaut P, Attali O, Dechavanne M, Négrier C. Ménart C, et al. Among authors: negrier c. Haemophilia. 1998 Sep;4(5):752-4. doi: 10.1046/j.1365-2516.1998.00176.x. Haemophilia. 1998. PMID: 9873882

3

Safety and efficacy of three arthroscopic procedures using Holmium: Yag laser in two high-responder haemophiliacs.

Ménart C, Lalain JJ, Lienhart A, Dechavanne M, Négrier C. Ménart C, et al. Among authors: negrier c. Haemophilia. 1999 Jul;5(4):278-81. doi: 10.1046/j.1365-2516.1999.00299.x. Haemophilia. 1999. PMID: 10469185

4

Prophylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcome.

Fischer K, van der Bom JG, Molho P, Negrier C, Mauser-Bunschoten EP, Roosendaal G, De Kleijn P, Grobbee DE, van den Berg HM. Fischer K, et al. Among authors: negrier c. Haemophilia. 2002 Nov;8(6):745-52. doi: 10.1046/j.1365-2516.2002.00695.x. Haemophilia. 2002. PMID: 12410642

5

Continuous intravenous infusion of a plasma-derived factor IX concentrate (Mononine) in haemophilia B.

Hoots WK, Leissinger C, Stabler S, Schwartz BA, White G, Dasani H, Massion C, Negrier C, Schindel F, Schulman S. Hoots WK, et al. Among authors: negrier c. Haemophilia. 2003 Mar;9(2):164-72. doi: 10.1046/j.1365-2516.2003.00721.x. Haemophilia. 2003. PMID: 12614367 Clinical Trial.

6

Haemophilia and thrombophilia: an unexpected association!

Dargaud Y, Meunier S, Negrier C. Dargaud Y, et al. Among authors: negrier c. Haemophilia. 2004 Jul;10(4):319-26. doi: 10.1111/j.1365-2516.2004.00906.x. Haemophilia. 2004. PMID: 15230944 Review.

7

Continuous infusion of B-domain deleted recombinant factor VIII (ReFacto) in patients with haemophilia A undergoing surgery: clinical experience.

Stieltjes N, Altisent C, Auerswald G, Négrier C, Pouzol P, Reynaud J, Roussel-Robert V, Savidge GF, Villar A, Schulman S. Stieltjes N, et al. Among authors: negrier c. Haemophilia. 2004 Sep;10(5):452-8. doi: 10.1111/j.1365-2516.2004.01013.x. Haemophilia. 2004. PMID: 15357770

8

Evaluation of the impact of information about treatment-related risks in patients receiving blood-derived or recombinant medications.

Magli-Barioz D, Ounnoughène N, Paugy P, Quarrè MC, Vassilief D, Lopez I, Goudemand J, Negrier C, Assogba U, Driss F, Dumont MA, Molho P. Magli-Barioz D, et al. Among authors: negrier c. Haemophilia. 2004 Sep;10(5):572-81. doi: 10.1111/j.1365-2516.2004.00930.x. Haemophilia. 2004. PMID: 15357786

9

Major surgery in a severe haemophilia A patient with high titre inhibitor: use of the thrombin generation test in the therapeutic decision.

Dargaud Y, Lienhart A, Meunier S, Hequet O, Chavanne H, Chamouard V, Marin S, Negrier C. Dargaud Y, et al. Among authors: negrier c. Haemophilia. 2005 Sep;11(5):552-8. doi: 10.1111/j.1365-2516.2005.01141.x. Haemophilia. 2005. PMID: 16128902

10

The pharmacokinetics of coagulation factors.

Lee M, Morfini M, Negrier C, Chamouard V. Lee M, et al. Among authors: negrier c. Haemophilia. 2006 Jul;12 Suppl 3:1-7. doi: 10.1111/j.1365-2516.2006.01253.x. Haemophilia. 2006. PMID: 16683990 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters